Infante, Jeffrey R.
Mendelson, David S.
Burris, Howard A. III
Bendell, Johanna C.
Tolcher, Anthony W.
Gordon, Michael S.
Gillenwater, Heidi H.
Arastu-Kapur, Shirin
Wong, Hansen L.
Papadopoulos, Kyriakos P.
Funding for this research was provided by:
Onyx Pharmaceuticals, Inc., an Amgen subsidiary
Article History
Received: 5 January 2016
Accepted: 1 February 2016
First Online: 29 February 2016
Compliance with ethical standards
:
: Jeffrey R. Infante, David S. Mendelson, Howard A. Burris III, Johanna C. Bendell, Michael S. Gordon, and KPP have no relevant conflicts of interest to disclose. Anthony W. Tolcher has received research funding from GSK. Heidi H. Gillenwater, Shirin Arastu-Kapur, and Hansen L. Wong are employed by Onyx.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, California.